Comparing Norethindrone vs Orilissa
Norethindrone | Orilissa (elagolix) |
|
---|
Norethindrone | Orilissa (elagolix) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Abnormal Uterine Bleeding, Endometriosis, Amenorrhea, Gender Affirming Hormone Therapy, Birth Control. Norethindrone may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Endometriosis. Orilissa may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||
More about Norethindrone | More about Orilissa (elagolix) | ||||||||
Ratings & Reviews | |||||||||
Norethindrone has an average rating of 4.9 out of 10 from a total of 1575 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 45% reported a negative effect. |
Orilissa has an average rating of 5.4 out of 10 from a total of 128 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 40% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Norethindrone side effects |
View all Orilissa side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Lower cost generic |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Orilissa prices |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
Affodel, Camila, Deblitane, Emzahh, Errin, Gallifrey, Heather, Incassia, Jencycla, Lyleq, Lyza, Meleya, Nor-QD, Norlyda, Norlyroc, Orquidea, Sharobel, Tulana View more |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
10 hours |
6 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 267 drugs are known to interact with Norethindrone:
|
A total of 375 drugs are known to interact with Orilissa:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
April 21, 1982 |
July 23, 2018 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.